Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2026-01-22 @ 9:48 AM
Study NCT ID:
NCT02785250
Status:
UNKNOWN
Last Update Posted:
2021-06-18
First Post:
2016-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
Sponsor:
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04
Start Date Type:
None
Primary Completion Date:
2020-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05
Completion Date Type:
ESTIMATED
First Submit Date:
2016-05-18
First Submit QC Date:
None
Study First Post Date:
2016-05-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-16
Last Update Post Date:
2021-06-18
Last Update Post Date Type:
ACTUAL